|
USP45 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.604160E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.376100E-02 |
| Normal-vs-Stage2 |
2.026800E-01 |
| Normal-vs-Stage3 |
1.557240E-03 |
| Normal-vs-Stage4 |
1.787720E-04 |
| Stage1-vs-Stage2 |
9.928600E-01 |
| Stage1-vs-Stage3 |
3.486200E-02 |
| Stage1-vs-Stage4 |
3.223400E-03 |
| Stage2-vs-Stage3 |
1.529020E-01 |
| Stage2-vs-Stage4 |
4.370400E-02 |
| Stage3-vs-Stage4 |
3.348200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.247800E-02 |
| Normal-vs-AfricanAmerican |
1.622440E-02 |
| Normal-vs-Asian |
7.376000E-02 |
| Caucasian-vs-AfricanAmerican |
3.943600E-01 |
| Caucasian-vs-Asian |
8.101600E-01 |
| AfricanAmerican-vs-Asian |
3.575400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.200280E-02 |
| Normal-vs-Female |
2.585900E-02 |
| Male-vs-Female |
5.149800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.857700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.745700E-02 |
| Normal-vs-Age(61-80Yrs) |
8.018000E-03 |
| Normal-vs-Age(81-100Yrs) |
9.438900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.744800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.690770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.180400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.689600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.873200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.253200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.096200E-02 |
| Classical-VS-Follicular |
9.540200E-01 |
| Classical-VS-Other |
4.037200E-01 |
| Classical-VS-Normal |
5.284300E-02 |
| Tall-VS-Follicular |
5.097500E-02 |
| Tall-VS-Other |
7.707600E-01 |
| Tall-VS-Normal |
1.275220E-03 |
| Follicular-VS-Other |
5.077800E-01 |
| Follicular-VS-Normal |
1.309420E-01 |
| Other-VS-Normal |
1.068360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.414500E-02 |
| Normal-vs-N1 |
1.159780E-02 |
| N0-vs-N1 |
3.167000E-01 |
|
|
